{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:05Z","timestamp":1791229505214,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1245\/s10434-019-07935-2","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T20:02:54Z","timestamp":1572984174000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)"],"prefix":"10.1245","volume":"27","author":[{"given":"Dario","family":"Baratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norfarizan","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Guaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Montenovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"7935_CR1","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717\u201325.","journal-title":"Int J Cancer."},{"key":"7935_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699\u2013705.","journal-title":"Br J Surg."},{"key":"7935_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","volume":"100","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010\u20132015: a systematic review. Crit Rev Oncol Hematol. 2016;100:209\u201322.","journal-title":"Crit Rev Oncol Hematol."},{"key":"7935_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol."},{"key":"7935_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YL Klaver","year":"2012","unstructured":"Klaver YL, Simkens LH, Lemmens VE, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38:617\u201323.","journal-title":"Eur J Surg Oncol."},{"key":"7935_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u201385.","journal-title":"J Clin Oncol."},{"key":"7935_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"7935_CR8","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","volume":"13","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol. 2012;13:e362\u20139.","journal-title":"Lancet Oncol."},{"key":"7935_CR9","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"7935_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jso.23464","volume":"109","author":"F Gremonprez","year":"2014","unstructured":"Gremonprez F, Willaert W, Ceelen W. Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models. J Surg Oncol. 2014;109:110\u20136.","journal-title":"J Surg Oncol."},{"key":"7935_CR11","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575\u201381.","journal-title":"Ann Surg Oncol."},{"key":"7935_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230\u201340.","journal-title":"N Engl J Med."},{"key":"7935_CR13","unstructured":"http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2018.36.18_suppl.LBA3503?af=R\n\n."},{"key":"7935_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","volume":"45","author":"W Ceelen","year":"2019","unstructured":"Ceelen W. HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road? Eur J Surg Oncol. 2019;45:400\u20132.","journal-title":"Eur J Surg Oncol."},{"key":"7935_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1245\/ASO.2004.09.008","volume":"11","author":"D Elias","year":"2004","unstructured":"Elias D, Delperro JR, Sideris L, et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol. 2004;11:518\u201321.","journal-title":"Ann Surg Oncol."},{"key":"7935_CR16","first-page":"650","volume":"56","author":"S Scaringi","year":"2009","unstructured":"Scaringi S, Leo F, Canonico G, Batignani G, Ficari F, Tonelli F. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin: a retrospective analysis with regard to multimodal treatments. Hepatogastroenterology. 2009;56:650\u20135.","journal-title":"Hepatogastroenterology."},{"key":"7935_CR17","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/bjs.7653","volume":"98","author":"J Mulsow","year":"2011","unstructured":"Mulsow J, Merkel S, Agaimy A, Hohenberger W. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg. 2011;98:1785\u201391.","journal-title":"Br J Surg."},{"key":"7935_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000320460","volume":"27","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Enomoto M, Higushi T, et al. Validation and clinical use of the Japanese classification of colorectal carcinomatosis: benefit of surgical cytoreduction, even without intraperitoneal chemotherapy. Dig Surg. 2010;27:473\u201380.","journal-title":"Dig Surg."},{"key":"7935_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10147-012-0505-6","volume":"19","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kotak, K., Sugihara, K, et al. Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry. Int J Clin Oncol. 2014;19:98\u2013105.","journal-title":"Int J Clin Oncol."},{"key":"7935_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jso.21169","volume":"99","author":"O Pelz","year":"2009","unstructured":"Pelz O, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J. Evaluation of a Peritoneal Surface Disease Severity Score in patients with colon cancer and peritoneal dissemination. J Surg Oncol. 2009;99:9\u201315.","journal-title":"J Surg Oncol."},{"key":"7935_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1245\/s10434-010-1522-1","volume":"18","author":"TC Chua","year":"2011","unstructured":"Chua TC, Morris DL, Saxena A, et al. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study. Ann Surg Oncol. 2011;18:1560-7.","journal-title":"Ann Surg Oncol."},{"key":"7935_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, Esquivel J, Lowy AM, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110:779\u201385.","journal-title":"J Surg Oncol."},{"key":"7935_CR23","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","volume":"57","author":"D Baratti","year":"2014","unstructured":"Baratti D, Kusamura S, Iusco D, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014;57:858\u201368.","journal-title":"Dis Colon Rectum."},{"key":"7935_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/DCR.0000000000001156","volume":"61","author":"D Baratti","year":"2018","unstructured":"Baratti D, Kusamura S, Iusco D, et al. Should a history of extra-peritoneal disease be a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer peritoneal metastases? Dis Colon Rectum. 2018;61:1026\u201334.","journal-title":"Dis Colon Rectum."},{"key":"7935_CR25","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386\u2013422.","journal-title":"Ann Oncol."},{"key":"7935_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jso.21388","volume":"100","author":"M Deraco","year":"2009","unstructured":"Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100:321\u20138.","journal-title":"J Surg Oncol."},{"key":"7935_CR27","first-page":"49","volume":"15","author":"P Jaquet","year":"1996","unstructured":"Jaquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"7935_CR28","unstructured":"http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf\n\n."},{"key":"7935_CR29","doi-asserted-by":"publisher","first-page":"e0122816","DOI":"10.1371\/journal.pone.0122816","volume":"10","author":"G D\u00e9solneux","year":"2015","unstructured":"D\u00e9solneux G, Mazi\u00e8re C, Vara J, et al. Cytoreductive surgery of colorectal peritoneal metastases: outcomes aftercomplete cytoreductive surgery and systemic chemotherapy only. PLoS One. 2015;10, e0122816.","journal-title":"PLoS One."},{"key":"7935_CR30","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","volume":"44","author":"M Bushati","year":"2018","unstructured":"Bushati M, Rovers KP, Sommariva A, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44:1942\u201348.","journal-title":"Eur J Surg Oncol."},{"key":"7935_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jso.23546","volume":"109","author":"D Hompes","year":"2014","unstructured":"Hompes D, D\u2019Hoore A, Wolthuis A, et al. The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. J Surg Oncol. 2014;109:527\u201332.","journal-title":"J Surg Oncol."},{"key":"7935_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","volume":"43","author":"V Leung","year":"2017","unstructured":"Leung V, Huo YR, Liauw W, Morris DL. Oxaliplatin versus mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43:144\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"7935_CR33","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jss.2012.01.015","volume":"179","author":"K Votanopoulos","year":"2013","unstructured":"Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179:e133\u20139.","journal-title":"J Surg Res."},{"key":"7935_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejso.2017.10.216","volume":"44","author":"WJ van Eden","year":"2018","unstructured":"van Eden WJ, Kok NFM, Woensdregt K, Huitema ADR, Boot H, Aalbers AGJ. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2018;44:220\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"7935_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1245\/s10434-016-5488-5","volume":"24","author":"D Baratti","year":"2017","unstructured":"Baratti D, Kusamura S, Iusco D, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of primary curative surgery in patients with colorectal cancer at high risk for metachronous peritoneal metastases. Ann Surg Oncol. 2017;24:167\u201375.","journal-title":"Ann Surg Oncol."},{"key":"7935_CR36","unstructured":"Ubink I, Bolhaqueiro ACF, Elias SG, et al. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg. [Epub ahead of print]."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07935-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07935-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07935-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:05:42Z","timestamp":1604448342000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07935-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["7935"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07935-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}